Response to assessment of urinary F2-isoprostanes in experimental and clinical studies: Mass spectrometry versus elisa

Norma B. Ojeda, Bettye Sue Hennington, Danielle T. Williamson, Melanie L. Hill, Nicole E.E. Betson, Julio C. Sartori-Valinotti, Jane F. Reckelhoff, Thomas P. Royals, Barbara T. Alexander

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)e15
JournalHypertension
Volume60
Issue number2
DOIs
StatePublished - Aug 1 2012

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Ojeda, N. B., Hennington, B. S., Williamson, D. T., Hill, M. L., Betson, N. E. E., Sartori-Valinotti, J. C., Reckelhoff, J. F., Royals, T. P., & Alexander, B. T. (2012). Response to assessment of urinary F2-isoprostanes in experimental and clinical studies: Mass spectrometry versus elisa. Hypertension, 60(2), e15. https://doi.org/10.1161/HYPERTENSIONAHA.112.199489